Review




Structured Review

STEMCELL Technologies Inc easysep tm human cd3 positive selection kit ii
Optimization of electroporation conditions for circRNA expression in <t>Human</t> <t>CD3</t> + T cells. A Comparison of EGFP expression in T cells electroporated with circRNA at different voltages (1400V, 1600V, and 1800V). B Flow cytometry analysis of anti-DLL3 CAR expression at varying electroporation voltages. C Evaluation of CAR expression and apoptosis rates in T cells electroporated with various concentrations of circRNA (1–6 µg/million cells). D Assessment of immunogenicity in circRNA and mRNA-transfected T cells under optimized electroporation conditions. E Assessment of CAR expression duration in circRNA and mRNA-transfected T cells. F Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CCK-8 assay. G Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CFSE assay. circRNA circular RNA, mRNA messenger RNA, EGFP enhanced green fluorescent protein, CAR-T chimeric antigen receptor T cell, DLL3 Delta-like Ligand 3, CCK-8 Cell Counting Kit-8, CFSE Carboxyfluorescein Succinimidyl Ester
Easysep Tm Human Cd3 Positive Selection Kit Ii, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/easysep+tm+human+cd3+positive+selection+kit+ii/pmc11905684-40-9-17?v=STEMCELL+Technologies+Inc
Average 90 stars, based on 1 article reviews
easysep tm human cd3 positive selection kit ii - by Bioz Stars, 2026-08
90/100 stars

Images

1) Product Images from "Engineered circular RNA-based DLL3-targeted CAR-T therapy for small cell lung cancer"

Article Title: Engineered circular RNA-based DLL3-targeted CAR-T therapy for small cell lung cancer

Journal: Experimental Hematology & Oncology

doi: 10.1186/s40164-025-00625-8

Optimization of electroporation conditions for circRNA expression in Human CD3 + T cells. A Comparison of EGFP expression in T cells electroporated with circRNA at different voltages (1400V, 1600V, and 1800V). B Flow cytometry analysis of anti-DLL3 CAR expression at varying electroporation voltages. C Evaluation of CAR expression and apoptosis rates in T cells electroporated with various concentrations of circRNA (1–6 µg/million cells). D Assessment of immunogenicity in circRNA and mRNA-transfected T cells under optimized electroporation conditions. E Assessment of CAR expression duration in circRNA and mRNA-transfected T cells. F Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CCK-8 assay. G Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CFSE assay. circRNA circular RNA, mRNA messenger RNA, EGFP enhanced green fluorescent protein, CAR-T chimeric antigen receptor T cell, DLL3 Delta-like Ligand 3, CCK-8 Cell Counting Kit-8, CFSE Carboxyfluorescein Succinimidyl Ester
Figure Legend Snippet: Optimization of electroporation conditions for circRNA expression in Human CD3 + T cells. A Comparison of EGFP expression in T cells electroporated with circRNA at different voltages (1400V, 1600V, and 1800V). B Flow cytometry analysis of anti-DLL3 CAR expression at varying electroporation voltages. C Evaluation of CAR expression and apoptosis rates in T cells electroporated with various concentrations of circRNA (1–6 µg/million cells). D Assessment of immunogenicity in circRNA and mRNA-transfected T cells under optimized electroporation conditions. E Assessment of CAR expression duration in circRNA and mRNA-transfected T cells. F Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CCK-8 assay. G Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CFSE assay. circRNA circular RNA, mRNA messenger RNA, EGFP enhanced green fluorescent protein, CAR-T chimeric antigen receptor T cell, DLL3 Delta-like Ligand 3, CCK-8 Cell Counting Kit-8, CFSE Carboxyfluorescein Succinimidyl Ester

Techniques Used: Electroporation, Expressing, Comparison, Flow Cytometry, Immunopeptidomics, Transfection, CCK-8 Assay, CFSE Assay, Cell Counting



Similar Products

90
STEMCELL Technologies Inc easysep tm human cd3 positive selection kit ii
Optimization of electroporation conditions for circRNA expression in <t>Human</t> <t>CD3</t> + T cells. A Comparison of EGFP expression in T cells electroporated with circRNA at different voltages (1400V, 1600V, and 1800V). B Flow cytometry analysis of anti-DLL3 CAR expression at varying electroporation voltages. C Evaluation of CAR expression and apoptosis rates in T cells electroporated with various concentrations of circRNA (1–6 µg/million cells). D Assessment of immunogenicity in circRNA and mRNA-transfected T cells under optimized electroporation conditions. E Assessment of CAR expression duration in circRNA and mRNA-transfected T cells. F Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CCK-8 assay. G Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CFSE assay. circRNA circular RNA, mRNA messenger RNA, EGFP enhanced green fluorescent protein, CAR-T chimeric antigen receptor T cell, DLL3 Delta-like Ligand 3, CCK-8 Cell Counting Kit-8, CFSE Carboxyfluorescein Succinimidyl Ester
Easysep Tm Human Cd3 Positive Selection Kit Ii, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/easysep+tm+human+cd3+positive+selection+kit+ii/pmc11905684-40-9-17?v=STEMCELL+Technologies+Inc
Average 90 stars, based on 1 article reviews
easysep tm human cd3 positive selection kit ii - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc easysep tm human cd19/cd3 positive selection kit ii
Optimization of electroporation conditions for circRNA expression in <t>Human</t> <t>CD3</t> + T cells. A Comparison of EGFP expression in T cells electroporated with circRNA at different voltages (1400V, 1600V, and 1800V). B Flow cytometry analysis of anti-DLL3 CAR expression at varying electroporation voltages. C Evaluation of CAR expression and apoptosis rates in T cells electroporated with various concentrations of circRNA (1–6 µg/million cells). D Assessment of immunogenicity in circRNA and mRNA-transfected T cells under optimized electroporation conditions. E Assessment of CAR expression duration in circRNA and mRNA-transfected T cells. F Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CCK-8 assay. G Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CFSE assay. circRNA circular RNA, mRNA messenger RNA, EGFP enhanced green fluorescent protein, CAR-T chimeric antigen receptor T cell, DLL3 Delta-like Ligand 3, CCK-8 Cell Counting Kit-8, CFSE Carboxyfluorescein Succinimidyl Ester
Easysep Tm Human Cd19/Cd3 Positive Selection Kit Ii, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/easysep+tm+human+cd3+positive+selection+kit+ii/pmc08909053-42-15-23?v=STEMCELL+Technologies+Inc
Average 90 stars, based on 1 article reviews
easysep tm human cd19/cd3 positive selection kit ii - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Optimization of electroporation conditions for circRNA expression in Human CD3 + T cells. A Comparison of EGFP expression in T cells electroporated with circRNA at different voltages (1400V, 1600V, and 1800V). B Flow cytometry analysis of anti-DLL3 CAR expression at varying electroporation voltages. C Evaluation of CAR expression and apoptosis rates in T cells electroporated with various concentrations of circRNA (1–6 µg/million cells). D Assessment of immunogenicity in circRNA and mRNA-transfected T cells under optimized electroporation conditions. E Assessment of CAR expression duration in circRNA and mRNA-transfected T cells. F Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CCK-8 assay. G Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CFSE assay. circRNA circular RNA, mRNA messenger RNA, EGFP enhanced green fluorescent protein, CAR-T chimeric antigen receptor T cell, DLL3 Delta-like Ligand 3, CCK-8 Cell Counting Kit-8, CFSE Carboxyfluorescein Succinimidyl Ester

Journal: Experimental Hematology & Oncology

Article Title: Engineered circular RNA-based DLL3-targeted CAR-T therapy for small cell lung cancer

doi: 10.1186/s40164-025-00625-8

Figure Lengend Snippet: Optimization of electroporation conditions for circRNA expression in Human CD3 + T cells. A Comparison of EGFP expression in T cells electroporated with circRNA at different voltages (1400V, 1600V, and 1800V). B Flow cytometry analysis of anti-DLL3 CAR expression at varying electroporation voltages. C Evaluation of CAR expression and apoptosis rates in T cells electroporated with various concentrations of circRNA (1–6 µg/million cells). D Assessment of immunogenicity in circRNA and mRNA-transfected T cells under optimized electroporation conditions. E Assessment of CAR expression duration in circRNA and mRNA-transfected T cells. F Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CCK-8 assay. G Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CFSE assay. circRNA circular RNA, mRNA messenger RNA, EGFP enhanced green fluorescent protein, CAR-T chimeric antigen receptor T cell, DLL3 Delta-like Ligand 3, CCK-8 Cell Counting Kit-8, CFSE Carboxyfluorescein Succinimidyl Ester

Article Snippet: CD3 + T cells were then purified employing the EasySep TM Human CD3 Positive Selection Kit II (Stemcell, 17851).

Techniques: Electroporation, Expressing, Comparison, Flow Cytometry, Immunopeptidomics, Transfection, CCK-8 Assay, CFSE Assay, Cell Counting